Keyword Connections

non-small-cell lung cancer

Journals

4

1 The Journal of antimicrobial chemotherapy

2 Future oncology (London, England)

3 Journal of medical imaging and radiation oncology

4 innovations (philadelphia, pa)

Research Groups

0

No Research Group Connected

Bibliographies

41

1 Surveillance After Treatment of Non-Small-Cell Lung Cancer: A Call for Multidisciplinary Standardization.

2 MicroRNA-122 negatively associates with peroxiredoxin-II expression in human gefitinib-resistant lung cancer stem cells

3 photobiomodulation of surgical wound dehiscence in a diabetic individual by low-level laser therapy following median sternotomy

4 feasibility, tolerability, and efficacy of the concurrent addition of erlotinib to thoracic radiotherapy in locally advanced unresectable non-small-cell lung cancer: a phase ii trial

5 apatinib plus icotinib in treating advanced non-small cell lung cancer after icotinib treatment failure: a retrospective study

6 Prognostic impact of immune inflammation biomarkers in predicting survival and radiosensitivity in patients with non-small-cell lung cancer treated with chemoradiotherapy.

7 Real-World Evidence of Safety and Efficacy of Carboplatin plus Nanoparticle Albumin-Bound Paclitaxel in Patients with Advanced Non-Small-Cell Lung Cancer and Preexisting Interstitial Lung Disease: A Retrospective Study

8 A Rare Delayed Atypical Pseudoprogression in Nivolumab-Treated Non-Small-Cell Lung Cancer

9 Retraction notice to “miR-1271 promotes non-small-cell lung cancer cell proliferation and invasion via targeting HOXA5” (Biochemical and Biophysical Research Communications (2015) 458(3) (714–719), (S0006291X1500251X), (10.1016/j.bbrc.2015.02.033))

10 Utilization pattern and service settings of palliative care for patients with metastatic non-small-cell lung cancer.

11 Data Analysis and Network Study of Non-small-cell Lung Cancer Biomarkers

12 Sotetsuflavone suppresses invasion and metastasis in non-small-cell lung cancer A549 cells by reversing EMT via the TNF-α/NF-κB and PI3K/AKT signaling pathway

13 Weekly paclitaxel in combination with carboplatin for advanced non-small-cell lung cancer complicated by idiopathic interstitial pneumonias: a single-arm phase II study.

14 Is there a different dose-effect relation between the primary tumor and involved lymph nodes in locally advanced non-small-cell lung cancer? A hypothesis-generating study.

15 Prospective Study of Patient-Reported Symptom Burden in Patients With Non-Small-Cell Lung Cancer Undergoing Proton or Photon Chemoradiation Therapy.

16 The Effect of Diabetes Mellitus on Prognosis of Patients with Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.

17 Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second-line or third-line treatment of patients with EGFR wild-type advanced non-small-cell lung cancer (ECOG-ACRIN 1512): a randomised, controlled, open-label, multicentre, phase 2 trial.

18 Predictors of benefits from frontline chemoimmunotherapy in stage IV non-small-cell lung cancer: a meta-analysis.

19 Radiotherapy for local recurrence of non-small-cell lung cancer after lobectomy and lymph node dissection-can local recurrence be radically cured by radiation?

20 Final progression-free survival results from the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer

21 Hsa_circ_0102533 serves as a blood-based biomarker for non-small-cell lung cancer diagnosis and regulates apoptosis in vitro.

22 Comparison of the efficacy and acute toxicity of weekly versus daily chemoradiotherapy for non-small-cell lung cancer: a meta-analysis.

23 Overcoming acquired resistance of epidermal growth factor receptor-mutant non-small-cell lung cancer cells to osimertinib by combining osimertinib with the histone deacetylase inhibitor panobinostat (LBH589).

24 Prognostic value of anthropometric measures extracted from whole-body CT using deep learning in patients with non-small-cell lung cancer.

25 A Nomogram for Predicting Cancer-Specific Survival of TNM 8th Edition Stage I Non-small-cell Lung Cancer.

26 Temozolomide plus whole brain radiotherapy for the treatment of non-small-cell lung cancer patients with brain metastases: A protocol of an updated systematic review and meta-analysis.

27 Impact of delaying initiation of anaplastic lymphoma kinase inhibitor treatment on survival in patients with advanced non-small-cell lung cancer.

28 Impact of somatic mutations on prognosis in resected non-small-cell lung cancer: The Japan Molecular Epidemiology for lung cancer study

29 treating advanced non-small-cell lung cancer in chinese patients: focus on icotinib

30 distribution and mrna expression of bambi in non-small-cell lung cancer

31 efficacy and safety of cox-2 inhibitors for advanced non-small-cell lung cancer with chemotherapy: a meta-analysis

32 new prognostic biomarkers and therapeutic effect of bevacizumab for patients with non-small-cell lung cancer

33 biomarkers in exhaled breath condensate and serum of chronic obstructive pulmonary disease and non-small-cell lung cancer

34 chemotherapy and egfr tyrosine kinase inhibitors for treatment of brain metastases from non-small-cell lung cancer: survival analysis in 210 patients

35 micrometastasis in non-small-cell lung cancer: detection and staging

36 advanced non-small-cell lung cancer in elderly patients: patient features and therapeutic management

37 the efficacy and safety of nivolumab in previously treated advanced non-small-cell lung cancer: a meta-analysis of prospective clinical trials

38 a new prognostic score based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer

39 systemic therapy in non-small-cell lung cancer

40 non-small-cell lung cancer clinicopathologic features and survival outcomes in asian pacific islanders residing in the united states: a seer analysis

41 pembrolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectives